McKesson (FRA:MCK) FFO


FRA:MCK McKesson Corp FRA:MCK
86 GF Score
Price €674.40
GF Value €698.32
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is McKesson FFO?

FFO (Funds from operations) only applies to REITs.

FRA:MCK
86GF Score
McKesson Corp FRA:MCK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is McKesson (FRA:MCK) Overvalued in 2026?

Based on GuruFocus' analysis, McKesson stock appears to be undervalued. The current stock price of €674.40 is trading 3.4% below its estimated GF Value™ of €698.32. GuruFocus considers McKesson to be Fairly Valued.

Key valuation signals for FRA:MCK:

  • FFO:
  • GF Value™: €698.32 vs. price of €674.40 (3.4% below fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the FRA:MCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
86GF Score

Get the complete analysis for FRA:MCK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€674.40
Price
€698.32
GF Value